483 BioMarin Pharmaceutical Feb 2005

483 BioMarin Pharmaceutical Feb 2005

Carolyn Renshaw FDA$119.00 - Available Now

FDA investigators audited the BioMarin Pharmaceutical - Novato, CA, United States facility and issued inspectional observations (via FDA 483) on 25 Feb 2005.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Feb 2005
  • Location: Novato, United States
  • FEI: 3004079983
Add To Cart